Related content

Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report

By Nucera Giuseppe   Mandato Vincenzo Dario   Gelli Maria Carolina   Palomba Stefano   La Sala Giovanni Battista  

Gynecological Endocrinology, Vol. 29, Iss. 3, 2013-03 ,pp. : 219-221

Informa Healthcare

Access to resources Recommend Favorite

Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer

By Onagawa T   Shibahara H     Machida S   Hirano Y   Hirashima C   Takamizawa S   Suzuki M  

Gynecological Endocrinology, Vol. 18, Iss. 6, 2004-06 ,pp. : 335-340

Informa Healthcare

Access to resources Recommend Favorite

Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature

By Pinto Evelin   Pinelo Sueli   Osório Marta   Ferreira Carla   Serra Helena   Pires Ilda   Barbosa António   Figueiredo Helena   Felgueira Eduarda   Tavares Angelina  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 545-548

Informa Healthcare

Access to resources Recommend Favorite

Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization

By Mohamed Kamel Abdelhakim   Davies William   Lashen Hany  

Gynecological Endocrinology, Vol. 22, Iss. 2, 2006-02 ,pp. : 57-62

Informa Healthcare

Access to resources Recommend Favorite

Relationship between gonadotropin releasing hormone agonist dosage and in vitro fertilization outcome

By Lorusso F.   Depalo R.   Selvaggi L.  

Gynecological Endocrinology, Vol. 18, Iss. 2, 2004-01 ,pp. : 69-73

Informa Healthcare

Access to resources Recommend Favorite